News

February 7, 2008
Genizon BioSciences Collaborating With London Genetics To Enhance Gene Discovery Findings In Schizophrenia (PDF)

January 7, 2008
Genizon BioSciences Secures $31 Million in Additional Financing (PDF)

November 6, 2007
Genizon BioSciences Collaborating with NDEI to Enhance Gene Discovery Findings in Schizophrenia (PDF)

September 5, 2007
Genizon BioSciences
Publishes Novel Genes
for Crohn's Disease
(PDF)

February 5, 2007
Genizon Secures $10 Million
in Additional Financing
(PDF)

 

Genizon BioSciences is a world leader in disease gene discovery and mapping, with programs in over 26 common diseases.

  • Genizon is the source for GeneMaps - comprehensive maps of genes, genetic markers, biochemical pathways and drug targets that are unequivocally involved in causing human disease.

  • Genizon's proprietary, industrialized gene discovery platform, using genome-wide association studies of thousands of members of the Quebec Founder Population, provides unprecedented understanding of the genetic origins and mechanisms of complex diseases.

  • Our research produces valuable intellectual property for pharmaceutical partners, accelerating the development of safer and more effective medicines.

Our Lead Programs

Genizon has completed genome-wide association studies in the following programs:

genetic research

Our Services

Genizon also offers rapid, top-quality genetic services at competitive prices:

snp genotyping